Recent observation highlighted the pivotal role of the expression of OX40, a member of the TNFR/TNF superfamily, on activated CD4+ and CD8+ T cells (32), in supporting Tregs fitness in mouse models of homeostatic proliferation and colitis and in promoting the expansion of stable and suppressive Tregs in human cancers (33–35). The gene discussed is CD8A; the disease is cancer.